American College Of Obstetricians And Gynecologists (ACOG) Annual Meeting

Obesity tied to multiple negative pregnancy and birth outcomes

Roshini Claire Anthony, 20200612140001

Women who are obese may have a host of pregnancy-related negative outcomes including pre-eclampsia and large for gestational age (LGA) infants, according to several studies from ACOG 2020.

Post-op enhanced recovery pathway cuts opioid use after C-sect

Multimodal analgesia cuts opioid use after C-section

Pearl Toh, 20200609190000

Implementation of the enhanced recovery after surgery (ERAS) protocols incorporating the use of scheduled multimodal analgesia reduced the need for opioid use in patients undergoing caesarean section (C-section), reveals a retrospective study presented at the ACOG 2020 Meeting.

Menstrual cup use linked to IUD expulsion

Roshini Claire Anthony, 20200609140001

Among women who use IUDs as contraception, concurrent use of a menstrual cup may increase the risk of IUD expulsion, according to a study presented at ACOG 2020.

Relugolix combo therapy preserves bone mass in women with HMB

Relugolix combo therapy preserves bone mass in women with heavy period

Pearl Toh, 20200602190000

Combining the oral GnRH* receptor antagonist relugolix together with oestradiol and the progestin norethindrone helps protect against bone loss induced by oestrogen deprivation associated with the use of GnRH receptor antagonist monotherapy for treating heavy menstrual bleeding, according to the LIBERTY studies released during the ACOG 2020 Meeting.

Subgroup findings boost elagolix benefit in uterine fibroid-induced menstrual bleeding

Audrey Abella, 20200529100000

The addition of the oral GnRH* antagonist elagolix to hormonal add-back therapy (E2/NETA**) reduces menstrual blood loss (MBL) in women with heavy menstrual bleeding (HMB) associated with uterine fibroids (UF) and comorbid adenomyosis, with the extension phase showing benefits beyond 6 months, according to data presented at ACOG 2020.

Vaginal cleansing prior to C-section reduces SSIs

Roshini Claire Anthony, 20200527140002

The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates.

GU symptoms down, sexual satisfaction up with new vaginal contraceptive gel

Audrey Abella, 20200526100000

A novel, investigational vaginal pH regulator (VPR) – a nonhormonal, water-based, petroleum-free contraceptive vaginal gel – improved genitourinary (GU) side effects and sexual satisfaction in women who are at risk of pregnancy but are not aiming to conceive, interim findings from the phase III AMPOWER* trial show.

Contraception with LNG-IUD still effective up to 6 years

Pearl Toh, 20200521190000

A levonorgestrel (LNG)-releasing intrauterine device (IUD) maintains high contraceptive efficacy up to 6 years, which is beyond the 5-year period it is currently approved for, according to data from the Mirena Extension Trial (MET) released during the ACOG 2020 Meeting.